12 weeks 3 vials 84 daily draws
found that GLP-1 can reduce oxidative stress in BV2 microglia by inhibiting the accumulation of intracellular ROS and release of nitric oxide (NO), as well as by increasing the expression of the antioxidant glutathione peroxidase 1 (GPx1) and superoxide dismutase 1 (SOD1) (184)
Available at: Ross, C., Morriss, A., Khairy, M., Khalaf, Y., Braude, P., Coomarasamy, A., & El-Toukhy, T
Change from Baseline (%) in BMI in Pediatric Patients with Obesity Aged 12 Years and Older in Study 10 with WEGOVY Injection Observed values for patients completing each scheduled visit, and estimates with multiple imputations from retrieved dropouts (RD-MI)
The potential for GLP-1 agonists to treat disorders like type-2 diabetes (T2D) was not lost on the endocrinology community (Reviewed here)
All models used non-informative priors